Literature DB >> 11884038

Mouse parthenogenetic embryos with monoallelic H19 expression can develop to day 17.5 of gestation.

Tomohiro Kono1, Yusuke Sotomaru, Yukiko Katsuzawa, Luisa Dandolo.   

Abstract

In mammals, both maternal and paternal genomes are required for a fetus to develop normally to term. This requirement is due to the epigenetic modification of genomes during gametogenesis, which leads to an unequivalent expression of imprinted genes between parental alleles. Parthenogenetic mouse embryos that contain genomes from nongrowing (ng) and fully grown (fg) oocytes can develop into 13.5-day-old fetuses, in which paternally and maternally expressed imprinted genes are expressed and repressed, respectively, from the ng oocyte allele. The H19 gene, however, is biallelically expressed with the silent status Igf2 in such parthenotes. In this study, we examined whether the regulation of H19 monoallelic expression enhances the survival of parthenogenetic embryos. The results clearly show that the ng(H19-KO)/fg(wt) parthenogenetic embryos carrying the ng-oocyte genome that had been deleted by the H19 transcription unit successfully developed as live fetuses for 17.5 gestation days. Control experiments revealed that this unique phenomenon occurs irrespective of the genetic background effect. Quantitative gene expression analysis showed that day 12.5 ng(H19-KO)/fg(wt) parthenogenetic fetuses expressed Igf2 and H19 genes at <2 and 82% of the levels in the controls. Histological analysis demonstrated that the placenta of ng(H19-KO)/fg(wt) parthenotes was afflicted with atrophia with severe necrosis and other anomalies. The present results suggest that the cessation of H19 gene expression from the ng-allele causes extended development of the fetus and that functional defects in the placenta could be fatal for the ontogeny. (C)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884038     DOI: 10.1006/dbio.2001.0561

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  7 in total

Review 1.  A natural stem cell therapy? How novel findings and biotechnology clarify the ethics of stem cell research.

Authors:  P Patel
Journal:  J Med Ethics       Date:  2006-04       Impact factor: 2.903

Review 2.  Concise review: parthenote stem cells for regenerative medicine: genetic, epigenetic, and developmental features.

Authors:  Brittany Daughtry; Shoukhrat Mitalipov
Journal:  Stem Cells Transl Med       Date:  2014-01-17       Impact factor: 6.940

3.  Downregulation of H19 improves the differentiation potential of mouse parthenogenetic embryonic stem cells.

Authors:  Neli P Ragina; Karianne Schlosser; Jason G Knott; Patricia K Senagore; Pamela J Swiatek; Eun Ah Chang; Walid D Fakhouri; Brian C Schutte; Matti Kiupel; Jose B Cibelli
Journal:  Stem Cells Dev       Date:  2011-09-14       Impact factor: 3.272

4.  The imprinted H19 noncoding RNA is a primary microRNA precursor.

Authors:  Xuezhong Cai; Bryan R Cullen
Journal:  RNA       Date:  2007-01-19       Impact factor: 4.942

5.  Ascorbic acid improves parthenogenetic embryo development through TET proteins in mice.

Authors:  Wei Gao; Xianfeng Yu; Jindong Hao; Ling Wang; Minghui Qi; Liang Han; Chao Lin; Dongxu Wang
Journal:  Biosci Rep       Date:  2019-01-11       Impact factor: 3.840

6.  Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cells.

Authors:  Hideki Ogino; Tadashige Nozaki; Akemi Gunji; Miho Maeda; Hiroshi Suzuki; Tsutomu Ohta; Yasufumi Murakami; Hitoshi Nakagama; Takashi Sugimura; Mitsuko Masutani
Journal:  BMC Genomics       Date:  2007-02-07       Impact factor: 3.969

Review 7.  Long non-coding RNA: its evolutionary relics and biological implications in mammals: a review.

Authors:  Jasdeep Kaur Dhanoa; Ram Saran Sethi; Ramneek Verma; Jaspreet Singh Arora; Chandra Sekhar Mukhopadhyay
Journal:  J Anim Sci Technol       Date:  2018-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.